Sign in

NCT00258544Active, not recruiting

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Brief summary (registry, in English)

This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead to new approaches to the diagnosis and treatment of pulmonary fibrosis.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
80 (actual)
First submitted
23 Nov 2005
Start date
Oct 2001
Primary completion date
Jul 2030
Lead sponsor
University of Pittsburgh
NCT number
NCT00258544

What you commit to

  • Study type: Observational
  • Participants enrolled: 80
  • From Oct 2001 to the primary completion date, Jul 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • N/A

Who the study is looking for

  • 18 years or age or older
  • Diagnosis of pulmonary fibrosis
  • Undergoing open lung biopsy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.